Prostate Cancer Newsfeed

… of new radiotherapy treatment for prostate cancer patients has praised the … as the standard for localised prostate cancer. Andrew Chan, Consultant Clinical … -intermediate risk prostate cancer not requiring concurrent hormone therapy.” Prostate cancer is the …

… current scientific understanding surrounding prostate cancer screening, evaluating the … for Prostate Cancer (ERSPC) demonstrated a relative reduction in prostate cancer … meticulously researched perspective on prostate cancer screening, delineating both …

… only to men whose prostate cancer had metastasised. However, … halves the risk of prostate cancer coming back and reduces … more healthy years." Prostate Cancer UK has campaigned for … treatments, with several new prostate cancer drugs rolled out over …

… to predict the risk for prostate cancer-specific mortality and highlight which … ; Stensland said. "Even though prostate cancer treatment is different now, our … Long-Term Risk for Prostate Cancer Mortality Following a Prostate-Specific Antigen Screening …

… funds supporting groundbreaking research like Prostate Cancer UK’s TRANSFORM trial, a … badge represents everyone effected by prostate cancer, including several people I know … important the funds raised are.” Prostate Cancer UK Chief Executive Laura Kerby …

… can help patients with recurrent prostate cancer delay progression, while delaying … men with oligorecurrent prostate cancer, meaning the cancer has come back … work together to treat oligorecurrent prostate cancer more effectively.  Individuals interested …

… funds supporting groundbreaking research like Prostate Cancer UK’s TRANSFORM trial, a … men havechecked their risk of prostate cancer during the tournament with over … ; its making a real difference.” Prostate Cancer UK Chief Executive Laura Kerby …

… 2025-26 championships, Prostate Cancer UK Chief Executive Laura … for groundbreaking research like Prostate Cancer UK’s TRANSFORM trial, … checked their risk of prostate cancer during the tournament … checking their risk of prostate cancer during the tournament, …

… strengthening our referral systems, expanding cancer treatment infrastructure, building a … commonly used to treat cervical, prostate and breast cancers. Health policy … integrated screening for cervical cancer, breast cancer and common non-communicable …

… . We’re serious about improving prostate cancer outcomes – treating it faster and … -based treatments, with several new prostate cancer drugs rolled over the last … accurately determine the presence of prostate cancer, its aggressiveness, and whether treatment …

… always mean the end of prostate cancer. Rising PSA levels after surgery … back. Some men with recurrent prostate cancer can be effectively cured by … radiotherapy directed to the prostate bed. But those whose disease …

… Team Men diagnosed with localised prostate cancer often look to the newest …

… classic car club cruised for cancer patients Friday, in Chula … their friend recovering from breast cancer. The cruise was all … of patients at the Barnhart Cancer Center at SHARP Chula … Dave Barker was diagnosed with prostate cancer last fall and says the …

… cost generic medicine, for advanced prostate cancer, having introduced a policy … also commissioned new innovative targeted prostate cancer therapies, including the branded drugs … “We’re serious about improving prostate cancer outcomes – treating it faster and …

… – University of Michigan  Newswise — Prostate cancer is the second-leading cause … ,” Stensland said. “Even though prostate cancer treatment is different now, our … Long-Term Risk for Prostate Cancer Mortality Following a Prostate-Specific Antigen Screening …

… Abiraterone works by starving prostate cancer of the hormones it needs … also commissioned several other targeted prostate cancer drugs, including enzalutamide, darolutamide, … 39;re serious about improving prostate cancer outcomes. Like the tireless …

… for patients with suspected prostate cancer, potentially increasing the use … histopathological evaluation of the suspected prostate cancer site, is recommended. Imaging … histopathological evaluation of the suspected prostate cancer site, is recommended. …

… halves the risk of prostate cancer coming back and … prostate cancer drugs rolled over the last five years." Prostate Cancer … of health improvement at Prostate Cancer UK, said: … re serious about improving prostate cancer outcomes - treating it …

… of Health Improvement, Prostate Cancer UK Amy Rylance, from Prostate Cancer UK, said: “This … abiraterone halves the risk of prostate cancer coming back and reduces risk … the long run.” What is prostate cancer? Prostate cancer affects a small, walnut shaped …

… linking specific dietary patterns to prostate cancer prevention or progression remain … patients with metastatic hormone-sensitive prostate cancer (NCT05832086), with end points … can be meaningfully integrated into prostate cancer management. REFERENCE 1. Lin …

… halves the risk of prostate cancer coming back and reduces … treatments, with several new prostate cancer drugs rolled over the … director of health improvement at Prostate Cancer UK, said: “This … , was diagnosed with aggressive prostate cancer in March 2023. He …

… Brighton, was diagnosed with aggressive prostate cancer in March 2023. He … Abiraterone tablets can help stop prostate cancer spreading Prostate Cancer UK's argument … effective treatment routinely available." Prostate Cancer UK is engaging with the …

… dying or of their cancer returning after treatment. Prostate cancer is the most … quagmire” over budgets, according to Prostate Cancer UK. This approval has followed … director of health improvement at Prostate Cancer UK, said: “This decision is …

… the support of campaigners including Prostate Cancer UK. The decision means about … -based treatments, with several new prostate cancer drugs rolled out over the … had not spread beyond the prostate. Prostate Cancer UK estimates the decision will …